Pricing

Advaxis, Inc (ADXS)

followers ·
Sector: HEALTH CARE
Industry: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS
CEO: Ken Berlin
Employees: 20
Web site: advaxis.com
9 DEER PARK DRIVE, SUITE K-1, MONMOUTH JUNCTION, NJ, 08852
732 545 1590

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

    Formally known as:
  • Advaxis Inc
  • Advaxis Inc
  • ADVAXIS INC (NEW) COM STK (DE)
  • ADVAXIS INC (NEW) COM STK (DE)
Stock Split History
Date Ratio
2013-07-15 1:125
2019-03-29 1:15
All 13F Filers Prior Change Hedge Funds 1 Prior Change
Advaxis, Inc. focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes (Lm) technology antigen delivery products in the United States. The company is developing ADXS-PSA, which is in Phase 2 clinical trials for the treatment of metastatic prostate cancer.
Please log in first to see chart
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available